[Federal Register Volume 66, Number 220 (Wednesday, November 14, 2001)]
[Notices]
[Page 57107]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-28426]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institutes of Health Guidelines for Research Using Human 
Pluripotent Stem Cells

ACTION: Notice; withdrawal of NIH Guidelines for Research Using 
Pluripotent Stem Cells Derived from Human Embryos (published August 25, 
2000, 65 FR 51976, correctedNovember 21, 2000, 65 FR 69951).

-----------------------------------------------------------------------

SUMMARY: The National Institutes of Health (NIH) announces the 
withdrawal of those sections of the NIH Guidelines for Research Using 
Human Pluripotent Stem Cells, http://www.nih.gov/news/stemcell/stemcellguidelines.htm. (NIH Guidelines), that pertain to research 
involving human pluripotent stem cells derived from human embryos that 
are the result of in vitro fertilization, are in excess of clinical 
need, and have not reached the stage at which the mesoderm is formed.
    The President has determined the criteria that allow Federal 
funding for research using existing embryonic stem cell lines, http://www.whitehouse.gov/news/releases/2001/08/print/20010809-1.html. Thus, 
the NIH Guidelines as they relate to human pluripotent stem cells 
derived from human embryos are no longer needed.

FOR FURTHER INFORMATION CONTACT:  NIH Office of Extramural Research, 
NIH, 1 Center Drive, MSC 0152, Building 1, Room 146, Bethesda, MD 
20892, or e-mail [email protected].

    Dated: November 2, 2001.
Ruth L. Kirschstein,
Acting Director, National Institutes of Health.
[FR Doc. 01-28426 Filed 11-13-01; 8:45 am]
BILLING CODE 4140-01-P